Psychiatry and Neurology, Neurology · Englewood, CO
NPI
1194013623
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
175 Inverness Dr W Ste 300
Englewood, CO, 80112
Phone (720) 516-0634
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
253 services
Medicare patients, 2024
153
Average age 67
Drug cost, 2024
$2.7M
909 prescriptions
Company payments, 2025
$5,738
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin Patel was code 99215 (office e&m - established), 86 times for 67 patients. In total Kevin Patel billed 253 services in 18 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 86 | 67 | $139.74 | $12K |
| 99214 Office E&M - Established | Office | 68 | 53 | $102.85 | $6,994 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $133.38 | $2,534 |
By year: 2022 $30K for 284 services; 2023 $34K for 297 services; 2024 $28K for 253 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin Patel prescribed most often to Medicare patients was Baclofen, with 105 prescriptions and refills. In total Kevin Patel wrote 909 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 105 | 226 | 28 | $4,352 |
| Gabapentin Generic | 93 | 147 | 18 | $2,354 |
| Dalfampridine Er Dalfampridine | 81 | 128 | 15 | $66K |
| Vumerity Diroximel Fumarate | 77 | 79 | Under 11 | $665K |
| Teriflunomide Generic | 48 | 56 | Under 11 | $45K |
| Dimethyl Fumarate Generic | 48 | 58 | Under 11 | $12K |
| Copaxone Glatiramer Acetate | 33 | 33 | Under 11 | $187K |
| Glatiramer Acetate Generic | 30 | 30 | Under 11 | $50K |
| Duloxetine Hcl Generic | 27 | 43 | Under 11 | $317 |
| Kesimpta Pen Ofatumumab | 24 | 28 | Under 11 | $241K |
| Tecfidera Dimethyl Fumarate | 21 | 21 | Under 11 | $191K |
| Modafinil Generic | 21 | 25 | Under 11 | $670 |
| Pregabalin Generic | 15 | 31 | Under 11 | $645 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 15 | 35 | Under 11 | $155K |
| Lidocaine Generic | 14 | 14 | Under 11 | $1,347 |
Brand drugs: 265 claims; generic drugs: 644 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin Patel $5,738 ($5,738 in general payments such as food, travel and fees) from 8 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $5,341.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.